NM_001395490.1:c.3458C>T
Variant summary
Our verdict is Likely benign. The variant received -4 ACMG points: 0P and 4B. BP4_Strong
The NM_001395490.1(TRERF1):c.3458C>T(p.Ala1153Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000291 in 1,613,970 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001395490.1 missense
Scores
Clinical Significance
Conservation
Publications
- complex neurodevelopmental disorderInheritance: AR Classification: LIMITED Submitted by: Ambry Genetics
Genome browser will be placed here
ACMG classification
Our verdict: Likely_benign. The variant received -4 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
TRERF1 | NM_001395490.1 | c.3458C>T | p.Ala1153Val | missense_variant | Exon 18 of 18 | ENST00000695948.1 | NP_001382419.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
TRERF1 | ENST00000695948.1 | c.3458C>T | p.Ala1153Val | missense_variant | Exon 18 of 18 | NM_001395490.1 | ENSP00000512293.1 |
Frequencies
GnomAD3 genomes AF: 0.0000526 AC: 8AN: 152142Hom.: 0 Cov.: 32 show subpopulations
GnomAD2 exomes AF: 0.000103 AC: 26AN: 251330 AF XY: 0.0000662 show subpopulations
GnomAD4 exome AF: 0.0000267 AC: 39AN: 1461828Hom.: 0 Cov.: 31 AF XY: 0.0000261 AC XY: 19AN XY: 727228 show subpopulations
GnomAD4 genome AF: 0.0000526 AC: 8AN: 152142Hom.: 0 Cov.: 32 AF XY: 0.0000673 AC XY: 5AN XY: 74322 show subpopulations
ClinVar
Submissions by phenotype
not specified Uncertain:1
The c.3422C>T (p.A1141V) alteration is located in exon 18 (coding exon 14) of the TRERF1 gene. This alteration results from a C to T substitution at nucleotide position 3422, causing the alanine (A) at amino acid position 1141 to be replaced by a valine (V). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at